Pleiotropic effects of statins on the cardiovascular system

A Oesterle, U Laufs, JK Liao - Circulation research, 2017 - Am Heart Assoc
The statins have been used for 30 years to prevent coronary artery disease and stroke. Their
primary mechanism of action is the lowering of serum cholesterol through inhibiting hepatic …

Reactive oxygen species: a key hallmark of cardiovascular disease

N Panth, KR Paudel, K Parajuli - Advances in medicine, 2016 - Wiley Online Library
Cardiovascular diseases (CVDs) have been the prime cause of mortality worldwide for
decades. However, the underlying mechanism of their pathogenesis is not fully clear yet. It …

Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика …

ВЮ Мареев, ИВ Фомин, ФТ Агеев, ЮЛ Беграмбекова… - Кардиология, 2018 - lib.ossn.ru
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп.
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …

[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …

VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …

Effect of Statins on Serum level of hs‐CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta‐Analysis of Randomized Controlled …

T Kandelouei, M Abbasifard, D Imani… - Mediators of …, 2022 - Wiley Online Library
Background. Several studies have reported that statins have anti‐inflammatory effects.
Nevertheless, results of clinical trials concerning the effect of statins on the levels of C …

NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases

A Fiordelisi, G Iaccarino, C Morisco, E Coscioni… - International journal of …, 2019 - mdpi.com
Inflammation is a key mechanism of cardiovascular diseases. It is an essential component of
atherosclerosis and a significant risk factor for the development of cardiovascular events. In …

Pleiotropic effects of statins

JK Liao, U Laufs - Annu. Rev. Pharmacol. Toxicol., 2005 - annualreviews.org
▪ Abstract Statins are potent inhibitors of cholesterol biosynthesis. In clinical trials, statins are
beneficial in the primary and secondary prevention of coronary heart disease. However, the …

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

L Tavazzi, AP Maggioni, R Marchioli… - Lancet (London …, 2008 - europepmc.org
Background Large observational studies, small prospective studies and post-hoc analyses
of randomised clinical trials have suggested that statins could be beneficial in patients with …

Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials

AS Antonopoulos, M Margaritis, R Lee… - Current …, 2012 - ingentaconnect.com
Ample evidence exists in support of the potent anti-inflammatory properties of statins. In cell
studies and animal models statins exert beneficial cardiovascular effects. By inhibiting …

Redox roles of reactive oxygen species in cardiovascular diseases

F He, L Zuo - International journal of molecular sciences, 2015 - mdpi.com
Cardiovascular disease (CVD), a major cause of mortality in the world, has been extensively
studied over the past decade. However, the exact mechanism underlying its pathogenesis …